Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries
Abstract
Authors
J van Stiphout P Vrouchou PG Braunhofer M Schwenkglenks TD Szucs P Blank